PNC Financial Services Group’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,803
Closed -$11.7K 4822
2024
Q3
$11.7K Hold
3,803
﹤0.01% 3746
2024
Q2
$24.7K Hold
3,803
﹤0.01% 3376
2024
Q1
$28.5K Buy
3,803
+1,574
+71% +$13.1K ﹤0.01% 3261
2023
Q4
$18.7K Sell
2,229
-1,371
-38% -$8.62K ﹤0.01% 3467
2023
Q3
$21.1K Buy
+3,600
New +$31.5K ﹤0.01% 3396
2020
Q3
Sell
-850
Closed -$9K 3953
2020
Q2
$9K Buy
+850
New +$9.22K ﹤0.01% 3492

Other funds holding EVGN

PNC Financial Services Group's EVGN Position: Q4 2024 in Review

PNC Financial Services Group sold out of Evogene (EVGN) in Q4 2024, closing a stake of 3,803 shares — an estimated $11.7K sold.

PNC Financial Services Group first reported a position in EVGN in Q2 2020 and held it in 6 quarters. The position peaked at $28.5K in Q1 2024. 15 funds tracked by Wall St. Rank hold EVGN as of Q4 2024.

  • PNC Financial Services Group reported no remaining Evogene position as of Q4 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 3,803 Evogene shares in Q4 2024, an estimated $11.7K.
  • PNC Financial Services Group first reported a position in Evogene in Q2 2020 and held it in 6 quarters.
  • PNC Financial Services Group's Evogene position peaked at $28.5K in Q1 2024.
  • 15 funds tracked by Wall St. Rank held Evogene as of Q4 2024.

Based on PNC Financial Services Group's 13F filing for Q4 2024, filed 7 Feb 2025.